TNN |
Q9UQP3
|
tenascin N
|
Signaling
|
1.6E-28 |
0.805 |
0.154 |
KCNK18 |
Q7Z418
|
potassium two pore domain channel subfamily K member 18
|
|
1.4E-03 |
0.780 |
0.192 |
ATP6V1C1 |
P21283
|
ATPase H+ transporting V1 subunit C1
|
Transporter
|
1.5E-04 |
0.821 |
0.192 |
RPLP2 |
P05387
|
ribosomal protein lateral stalk subunit P2
|
|
0.67 |
0.805 |
0.192 |
GLG1 |
Q92896
|
golgi glycoprotein 1
|
|
1.00 |
0.821 |
0.192 |
SLC4A9 |
Q96Q91
|
solute carrier family 4 member 9
|
Transporter
|
3.2E-22 |
0.839 |
0.192 |
MGR1 |
|
Migraine with aura, susceptibility to
|
|
|
0.821 |
0.231 |
MIR466 |
|
microRNA 466
|
|
|
0.722 |
0.269 |
LRATD2 |
Q96KN1
|
LRAT domain containing 2
|
|
3.7E-04 |
0.751 |
0.269 |
PGLS |
O95336
|
6-phosphogluconolactonase
|
Enzyme
|
7.5E-04 |
0.769 |
0.269 |
CLEC3B |
P05452
|
C-type lectin domain family 3 member B
|
Extracellular structure
|
2.1E-03 |
0.729 |
0.308 |
DRG1 |
Q9Y295
|
developmentally regulated GTP binding protein 1
|
|
0.33 |
0.682 |
0.346 |
CLLS2 |
|
Disrupted in B-cell neoplasia
|
|
|
0.678 |
0.346 |
COPS3 |
Q9UNS2
|
COP9 signalosome subunit 3
|
Enzyme modulator
|
1.00 |
0.729 |
0.346 |
RAI2 |
Q9Y5P3
|
retinoic acid induced 2
|
|
0.61 |
0.751 |
0.346 |
SDCBP |
O00560
|
syndecan binding protein
|
Transporter
|
5.8E-04 |
0.653 |
0.385 |
MRC2 |
Q9UBG0
|
mannose receptor C type 2
|
|
0.67 |
0.705 |
0.385 |
FZD8 |
Q9H461
|
frizzled class receptor 8
|
G-protein coupled receptor
|
0.79 |
0.674 |
0.385 |
FUT6 |
P51993
|
fucosyltransferase 6
|
Enzyme
|
|
0.695 |
0.385 |
DCAF6 |
Q58WW2
|
DDB1 and CUL4 associated factor 6
|
Enzyme modulator
|
8.6E-02 |
0.729 |
0.385 |
VTA1 |
Q9NP79
|
vesicle trafficking 1
|
|
4.0E-04 |
0.641 |
0.423 |
KLK2 |
P20151
|
kallikrein related peptidase 2
|
Enzyme
|
1.3E-04 |
0.653 |
0.423 |
RHOB |
P62745
|
ras homolog family member B
|
Enzyme modulator
|
0.12 |
0.653 |
0.423 |
DOCK4 |
Q8N1I0
|
dedicator of cytokinesis 4
|
|
0.83 |
0.666 |
0.423 |
CAVIN3 |
Q969G5
|
caveolae associated protein 3
|
Transcription factor
|
8.0E-05 |
0.674 |
0.423 |